Rapid targeted gene disruption in Bacillus anthracis

BMC Biotechnology

Volumn 13, Issue , 2013, Pages

  Saldanha, Roland J ^a   Pemberton, Adin ^a   Shiflett, Patrick ^b   Perutka, Jiri ^c   Whitt, Jacob T ^c   Ellington, Andrew ^c   Lambowitz, Alan M ^c   Kramer, Ryan ^d,e   Taylor, Deborah ^d   Lamkin, Thomas J ^d  

^a UES INC   (United States)

^b Henry Jackson Foundation   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^d AIR FORCE RESEARCH LABORATORY   (United States)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACILLUS ANTHRACIS; BACTERIAL CHROMOSOMES; GENE INACTIVATION; HIGH-QUALITY SEQUENCES; SELECTION SCHEME; TRANSFORMATION EFFICIENCY; VECTOR CONSTRUCTION; ZOONOTIC DISEASE;

DIAGNOSIS; TOOLS;

GENES;

ANTHRAX; ANTIBIOTIC RESISTANCE; ARTICLE; BACILLUS ANTHRACIS; GENE DISRUPTION; GENE INACTIVATION; GENE INSERTION; GENETIC SELECTION; INTRON; NONHUMAN; POLYMERASE CHAIN REACTION;

BACILLUS ANTHRACIS; BACTERIA (MICROORGANISMS);

BACILLUS ANTHRACIS; CHROMOSOMES, BACTERIAL; CLONING, MOLECULAR; DNA, BACTERIAL; ESCHERICHIA COLI; GENE TARGETING; GENES, BACTERIAL; GENETIC VECTORS; INTRONS; MUTAGENESIS, INSERTIONAL; NUCLEIC ACID CONFORMATION; PLASMIDS; SELECTION, GENETIC;

EID: 84884191653     PISSN: None     EISSN: 14726750     Source Type: Journal    
DOI: 10.1186/1472-6750-13-72     Document Type: Article

References (35)

1. Koch R. Die Ätiologie der Milzbrand Krankheit begründet auf die Entwicklungsgeschichte des Bacillus anthracis. Beitr Biol Pflanz 1876, 2:277-283.
2. Beyer W, Turnbull PC. Anthrax in animals. Molecular aspects of medicine 2009, 30(6):481-489. 10.1016/j.mam.2009.08.004, 19723532.
3. Keim P, Van Ert MN, Pearson T, Vogler AJ, Huynh LY, Wagner DM. Anthrax molecular epidemiology and forensics: using the appropriate marker for different evolutionary scales. Infection, genetics and evolution: journal of molecular epidemiology and evolutionary genetics in infectious diseases 2004, 4(3):205-213. 10.1016/j.meegid.2004.02.005, 15450200.
4. Cote CK, Welkos SL, Bozue J. Key aspects of the molecular and cellular basis of inhalational anthrax. Microbes and infection / Institut Pasteur 2011, 13(14-15):1146-1155.
5. WHO Anthrax in humans and animals 2008, Geneva 27, Switzerland: WHO Press, WHO.
6. Okinaka RT, Cloud K, Hampton O, Hoffmaster AR, Hill KK, Keim P, Koehler TM, Lamke G, Kumano S, Mahillon J, et al. Sequence and organization of pXO1, the large Bacillus anthracis plasmid harboring the anthrax toxin genes. J Bacteriol 1999, 181(20):6509-6515. 103788, 10515943.
7. Bouzianas DG. Medical countermeasures to protect humans from anthrax bioterrorism. Trends in microbiology 2009, 17(11):522-528. 10.1016/j.tim.2009.08.006, 19781945.
8. Meselson M, Guillemin J, Hugh-Jones M, Langmuir A, Popova I, Shelokov A, Yampolskaya O. The Sverdlovsk anthrax outbreak of 1979. Science 1994, 266(5188):1202-1208. 10.1126/science.7973702, 7973702.
9. Atlas RM. Bioterriorism: from threat to reality. Annu Rev Microbiol 2002, 56:167-185. 10.1146/annurev.micro.56.012302.160616, 12142472.
10. Ravel J, Jiang L, Stanley ST, Wilson MR, Decker RS, Read TD, Worsham P, Keim PS, Salzberg SL, Fraser-Liggett CM, et al. The complete genome sequence of Bacillus anthracis Ames " Ancestor". J Bacteriol 2009, 191(1):445-446. 10.1128/JB.01347-08, 2612425, 18952800.
11. Read TD, Peterson SN, Tourasse N, Baillie LW, Paulsen IT, Nelson KE, Tettelin H, Fouts DE, Eisen JA, Gill SR, et al. The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteria. Nature 2003, 423(6935):81-86. 10.1038/nature01586, 12721629.
12. Janes BK, Stibitz S. Routine markerless gene replacement in Bacillus anthracis. Infection and immunity 2006, 74(3):1949-1953. 10.1128/IAI.74.3.1949-1953.2006, 1418658, 16495572.
13. Pomerantsev AP, Sitaraman R, Galloway CR, Kivovich V, Leppla SH. Genome engineering in Bacillus anthracis using Cre recombinase. Infection and immunity 2006, 74(1):682-693. 10.1128/IAI.74.1.682-693.2006, 1346652, 16369025.
14. Shatalin KY, Neyfakh AA. Efficient gene inactivation in Bacillus anthracis. FEMS Microbiol Lett 2005, 245(2):315-319. 10.1016/j.femsle.2005.03.029, 15837388.
15. Koehler TM. Bacillus anthracis physiology and genetics. Molecular aspects of medicine 2009, 30(6):386-396. 10.1016/j.mam.2009.07.004, 2784286, 19654018.
16. Lambowitz AM, Zimmerly S. Group II introns: mobile ribozymes that invade DNA. Cold Spring Harbor perspectives in biology 2011, 3(8):a003616. 10.1101/cshperspect.a003616, 3140690, 20463000.
17. Karberg M, Guo H, Zhong J, Coon R, Perutka J, Lambowitz AM. Group II introns as controllable gene targeting vectors for genetic manipulation of bacteria. Nature biotechnology 2001, 19(12):1162-1167. 10.1038/nbt1201-1162, 11731786.
18. Akhtar P, Khan SA. Two independent replicons can support replication of the anthrax toxin-encoding plasmid pXO1 of Bacillus anthracis. Plasmid 2012, 67(2):111-117. 10.1016/j.plasmid.2011.12.012, 22239982.
19. Perutka J, Wang W, Goerlitz D, Lambowitz AM. Use of computer-designed group II introns to disrupt Escherichia coli DExH/D-box protein and DNA helicase genes. J Mol Biol 2004, 336(2):421-439. 10.1016/j.jmb.2003.12.009, 14757055.
20. Rawsthorne H, Turner KN, Mills DA. Multicopy integration of heterologous genes, using the lactococcal group II intron targeted to bacterial insertion sequences. Appl Environ Microbiol 2006, 72(9):6088-6093. 10.1128/AEM.02992-05, 1563669, 16957233.
21. Saldanha R, Mohr G, Belfort M, Lambowitz AM. Group I and group II introns. The FASEB journal: official publication of the Federation of American Societies for Experimental Biology 1993, 7(1):15-24.
22. Zimmerly S, Guo H, Perlman PS, Lambowitz AM. Group II intron mobility occurs by target DNA-primed reverse transcription. Cell 1995, 82(4):545-554. 10.1016/0092-8674(95)90027-6, 7664334.
23. Zimmerly S, Guo H, Eskes R, Yang J, Perlman PS, Lambowitz AM. A group II intron RNA is a catalytic component of a DNA endonuclease involved in intron mobility. Cell 1995, 83(4):529-538. 10.1016/0092-8674(95)90092-6, 7585955.
24. Guo H, Zimmerly S, Perlman PS, Lambowitz AM. Group II intron endonucleases use both RNA and protein subunits for recognition of specific sequences in double-stranded DNA. The EMBO journal 1997, 16(22):6835-6848. 10.1093/emboj/16.22.6835, 1170287, 9362497.
25. Matsuura M, Saldanha R, Ma H, Wank H, Yang J, Mohr G, Cavanagh S, Dunny GM, Belfort M, Lambowitz AM. A bacterial group II intron encoding reverse transcriptase, maturase, and DNA endonuclease activities: biochemical demonstration of maturase activity and insertion of new genetic information within the intron. Genes & development 1997, 11(21):2910-2924. 10.1101/gad.11.21.2910, 24052944.
26. Saldanha R, Chen B, Wank H, Matsuura M, Edwards J, Lambowitz AM. RNA and protein catalysis in group II intron splicing and mobility reactions using purified components. Biochemistry 1999, 38(28):9069-9083. 10.1021/bi982799l, 10413481.
27. Singh NN, Lambowitz AM. Interaction of a group II intron ribonucleoprotein endonuclease with its DNA target site investigated by DNA footprinting and modification interference. J Mol Biol 2001, 309(2):361-386. 10.1006/jmbi.2001.4658, 11371159.
28. Charpentier E, Anton AI, Barry P, Alfonso B, Fang Y, Novick RP. Novel cassette-based shuttle vector system for gram-positive bacteria. Appl Environ Microbiol 2004, 70(10):6076-6085. 10.1128/AEM.70.10.6076-6085.2004, 522135, 15466553.
29. Bruckner R. A series of shuttle vectors for Bacillus subtilis and Escherichia coli. Gene 1992, 122(1):187-192. 10.1016/0378-1119(92)90048-T, 1452028.
30. Zhong J, Karberg M, Lambowitz AM. Targeted and random bacterial gene disruption using a group II intron (targetron) vector containing a retrotransposition-activated selectable marker. Nucleic Acids Res 2003, 31(6):1656-1664. 10.1093/nar/gkg248, 152852, 12626707.
31. Gat O, Inbar I, Aloni-Grinstein R, Zahavy E, Kronman C, Mendelson I, Cohen S, Velan B, Shafferman A. Use of a promoter trap system in Bacillus anthracis and Bacillus subtilis for the development of recombinant protective antigen-based vaccines. Infection and immunity 2003, 71(2):801-813. 10.1128/IAI.71.2.801-813.2003, 145393, 12540560.
32. Marrero R, Welkos SL. The transformation frequency of plasmids into Bacillus anthracis is affected by adenine methylation. Gene 1995, 152(1):75-78. 10.1016/0378-1119(94)00647-B, 7828932.
33. Yao J, Zhong J, Fang Y, Geisinger E, Novick RP, Lambowitz AM. Use of targetrons to disrupt essential and nonessential genes in staphylococcus aureus reveals temperature sensitivity of Ll.LtrB group II intron splicing. Rna 2006, 12(7):1271-1281. 10.1261/rna.68706, 1484445, 16741231.
34. Sambrook Russel DW. Molecular cloning: a laboratory manual 2001, NY: Cold Spring Harbor Press.
35. Koehler TM, Dai Z, Kaufman-Yarbray M. Regulation of the Bacillus anthracis protective antigen gene: CO2 and a trans-acting element activate transcription from one of two promoters. J Bacteriol 1994, 176(3):586-595. 205094, 8300513.